| Literature DB >> 35736118 |
Zhen Yao1,2, Qinhong Wang1,2, Zongjie Dai1,2.
Abstract
Saccharomyces cerevisiae, as a Generally Recognized as Safe (GRAS) fungus, has become one of the most widely used chassis cells for industrial applications and basic research. However, owing to its complex genetic background and intertwined metabolic networks, there are still many obstacles that need to be overcome in order to improve desired traits and to successfully link genotypes to phenotypes. In this context, genome editing and evolutionary technology have rapidly progressed over the last few decades to facilitate the rapid generation of tailor-made properties as well as for the precise determination of relevant gene targets that regulate physiological functions, including stress resistance, metabolic-pathway optimization and organismal adaptation. Directed genome evolution has emerged as a versatile tool to enable researchers to access desired traits and to study increasingly complicated phenomena. Here, the development of directed genome evolutions in S. cerevisiae is reviewed, with a focus on different techniques driving evolutionary engineering.Entities:
Keywords: CRISPR/Cas9; SCRaMbLE; Saccharomyces cerevisiae; evolutionary engineering; synthetic biology
Year: 2022 PMID: 35736118 PMCID: PMC9225242 DOI: 10.3390/jof8060635
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Summary of genome evolutionary engineering. (a) Fusion of ssDNA-binding protein and cytidine deaminase. (b) CIRSPRi/CRISPRa. (c) SCRaMbLE in vivo provides a versatile platform to generate diverse genetic variants. (d) SCRaMbLE in vitro is conducted via purified Cre in tube and the obtained library is transformed into S. cerevisiae to generate diverse phenotypes. (e) Directional cloning obtained from cDNA simultaneously realized up- and downregulations.
Genome evolutionary-engineering methods by CRISPR/Cas9.
| Name | Description | gRNA | Applications | Reference |
|---|---|---|---|---|
| CRISPRi | dCas12a-Mxi1 | Targeting heterologous β-carotene biosynthesis pathway genes crtE, crtYB, crtI | β-carotene production | [ |
| dCas9 | Targeting | N-acetylglucosamine production | [ | |
| dCas9 | Targeting seven genes in branch pathways of β-amyrin production | β-amyrin production | [ | |
| dCas9-Mxi1 | Targeting over 98% of essential and respiratory growth-essential genes | Acetic-acid Tolerance | [ | |
| dCas9-Mxi1 | Targeting transcription start site (TSS) in genome scale | Mining of haploinsufficient genes and identification of adenine and arginine biosynthesis genes | [ | |
| dCas9-Mxi1 | Targeting 161 transcriptional factors and 129 protein kinase | Growth in lignocellulose hydrolysate | [ | |
| CRISPRa | dCas9-VP64 | Targeting 52 genes | Thermotolerance | [ |
| CHAnGE | Global deletion of genes from genome by homologous recombination via gRNA and donor synthesized on chip | Synthesized on chip in ~100% gene coverage | Acetic acid and furfural tolerance | [ |
| STEPS | Combination of dCas9-Mix1 and dCas9-VPR to simultaneously up- and downregulate transcriptional levels, respectively | Graded targeting of genes involved in glycerol production, PPP genes for 3-DHS production and xylose catabolism | Glycerol and 3-DHS production, xylose catabolism | [ |
| CRSPRi/a | Cas9-VPR | Four genes | α-santalene production | [ |
| CRSPRi/a | dCas9 or dCas9-Mxi1dCas9-VP64 or dCas9-VPR | Targeting four genes | Tolerance towards lignocellulosic hydrolysate. | [ |
| MAGIC | Combination of dLbCas12a-VP, dSpCas9-RD1152 and SaCas9 to simultaneously upregulate, downregulate and delete genes, respectively | Synthesized on chip in ~100% gene coverage | GAL7 and HED1 expression levels | [ |